神経治療学
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
特集 神経治療における小児-成人移行医療
免疫性神経疾患の移行医療
奥野 龍禎矢田 知大
著者情報
ジャーナル フリー

2022 年 39 巻 2 号 p. 72-77

詳細
抄録

An improvement in efficacy treatment and development of the social support system has led to many patients with neuroimmunological disorders being able to reach adulthood

Most of them are treated by pediatricians at first and followed by neurologists when the patient reaches adulthood. Child–onset neuroimmune diseases may have different symptoms from adult–onset cases, and in some cases, diagnostic criteria, treatment guidelines, and social welfare systems may also differ. Though most cases of child–onset neuroimmune diseases are thought to become independent from their parents finally because higher brain dysfunction is not as prominent as in severe psychosomatic disorders, parents may be present during the decision–making and explanation of the treatment plan at the beginning of the transition to neurologists, and it is important to pay attention to them. In this article, we will focus on central nervous system demyelinating diseases (multiple sclerosis, neuromyelitis optica spectrum disorders, MOG antibody–related diseases), and outline the clinical features, applicable diagnostic criteria, social welfare systems, and treatment of these diseases in children.

著者関連情報
© 2022 日本神経治療学会
前の記事 次の記事
feedback
Top